CRANBURY, N.J., March 9, 2017 /PRNewswire/ -- Palatin
Technologies, Inc. (NYSE MKT: PTN) announced today that it will be
presenting at the 29th Annual ROTH Conference on
Tuesday, March 14, 2017, at
11:00 a.m. Pacific Time. The
conference will be held at The Ritz Carlton Laguna Niguel in
Dana Point, CA.
Carl Spana, Ph.D., President and
Chief Executive Officer of Palatin Technologies, will provide an
update on Palatin's corporate and development programs.
About Palatin Technologies, Inc.
Palatin
Technologies, Inc. is a biopharmaceutical company developing
targeted, receptor-specific peptide therapeutics for the treatment
of diseases with significant unmet medical need and commercial
potential. Palatin's strategy is to develop products and then form
marketing collaborations with industry leaders in order to maximize
their commercial potential. For additional information
regarding Palatin, please visit Palatin's website at
www.palatin.com.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/palatin-technologies-to-present-at-the-29th-annual-roth-conference-300421437.html
SOURCE Palatin Technologies, Inc.